OncoResponse’s discovery platform mines the immune systems of patients who have responded particularly well to cancer immunotherapies.
Read the original here:
OncoResponse raises $40 million to kickstart immunotherapy drug development
OncoResponse raises $40 million to kickstart immunotherapy drug development
Over the years, through our many assignments, the Principals of Revitalization Partners frequently said to ourselves: “One day, we should write a book about our work and how we can help companies through our experiences.” This is that book and we hope that you find words of value to you and your business.